[
  {
    "ts": null,
    "headline": "Trump's drug price order is part request, part threat: Analyst",
    "summary": "President Trump signed an executive order on Monday calling for pharmaceutical companies to cut their drug prices for US consumers. Bernstein Senior Analyst, US Biopharmaceuticals Courtney Breen comments on whether the Trump administration ultimately has the power to force drug companies to do this. To watch more expert insights and analysis on the latest market action, check out more Market Domination here.",
    "url": "https://finnhub.io/api/news?id=d8f897935ba7a4a50063a61fa2f24998fe9bf1ec2d00f6721ed8763caed00d7f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747092000,
      "headline": "Trump's drug price order is part request, part threat: Analyst",
      "id": 134408474,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "President Trump signed an executive order on Monday calling for pharmaceutical companies to cut their drug prices for US consumers. Bernstein Senior Analyst, US Biopharmaceuticals Courtney Breen comments on whether the Trump administration ultimately has the power to force drug companies to do this. To watch more expert insights and analysis on the latest market action, check out more Market Domination here.",
      "url": "https://finnhub.io/api/news?id=d8f897935ba7a4a50063a61fa2f24998fe9bf1ec2d00f6721ed8763caed00d7f"
    }
  },
  {
    "ts": null,
    "headline": "S&P, Dow Pharma Stocks Boomerang On Drug-Pricing Order That Is 'All Bark' And 'Little Bite'",
    "summary": "Pharmaceutical stocks boomeranged Monday after Trump signed an executive order tying drug prices in the U.S. to international price tags.",
    "url": "https://finnhub.io/api/news?id=e47244c465885beed6f1ca595ff644dcf2ed5efc962b3620a570a6251ee670b2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747081543,
      "headline": "S&P, Dow Pharma Stocks Boomerang On Drug-Pricing Order That Is 'All Bark' And 'Little Bite'",
      "id": 134408475,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Pharmaceutical stocks boomeranged Monday after Trump signed an executive order tying drug prices in the U.S. to international price tags.",
      "url": "https://finnhub.io/api/news?id=e47244c465885beed6f1ca595ff644dcf2ed5efc962b3620a570a6251ee670b2"
    }
  },
  {
    "ts": null,
    "headline": "These Stocks Moved the Most Today: Amazon, Nvidia, Tesla, Alibaba, Eli Lilly, Pfizer, NRG Energy, Newmont, and More",
    "summary": "Amazon.com, Nvidia, Tesla, and the rest of the Magnificent Seven stocks jump as the U.S. and China reach an agreement to temporarily slash most tariffs on each other’s goods.",
    "url": "https://finnhub.io/api/news?id=5e959369a511b99d18477e21bc3fe6d2482e60c20f3e7747156cdb489787a33e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747081020,
      "headline": "These Stocks Moved the Most Today: Amazon, Nvidia, Tesla, Alibaba, Eli Lilly, Pfizer, NRG Energy, Newmont, and More",
      "id": 134408477,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Amazon.com, Nvidia, Tesla, and the rest of the Magnificent Seven stocks jump as the U.S. and China reach an agreement to temporarily slash most tariffs on each other’s goods.",
      "url": "https://finnhub.io/api/news?id=5e959369a511b99d18477e21bc3fe6d2482e60c20f3e7747156cdb489787a33e"
    }
  },
  {
    "ts": null,
    "headline": "Trump calls out weight-loss drugs as target of price-cut push",
    "summary": "(Reuters) -The Trump administration on Monday singled out powerful new weight-loss drugs including Wegovy and Zepbound as targets in its push to lower prescription drug prices.  President Donald Trump's executive order demands that drugmakers cut prices on their products in the coming months to hew more closely to what they charge in other developed countries, or face new regulations and enforcement actions, from export restrictions to tariffs.  At the signing ceremony, Trump described a conversation with a businessman friend who lamented how much more expensive weight-loss treatments are in the United States.",
    "url": "https://finnhub.io/api/news?id=69d4fb51b81845cd910aefcee27d15eeb7116e656cdd486aba7e6ddfe88095e9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747080574,
      "headline": "Trump calls out weight-loss drugs as target of price-cut push",
      "id": 134408479,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "(Reuters) -The Trump administration on Monday singled out powerful new weight-loss drugs including Wegovy and Zepbound as targets in its push to lower prescription drug prices.  President Donald Trump's executive order demands that drugmakers cut prices on their products in the coming months to hew more closely to what they charge in other developed countries, or face new regulations and enforcement actions, from export restrictions to tariffs.  At the signing ceremony, Trump described a conversation with a businessman friend who lamented how much more expensive weight-loss treatments are in the United States.",
      "url": "https://finnhub.io/api/news?id=69d4fb51b81845cd910aefcee27d15eeb7116e656cdd486aba7e6ddfe88095e9"
    }
  },
  {
    "ts": null,
    "headline": "How Trump could go about executing order to slash drug prices",
    "summary": "President Trump signed an executive order on Monday asking drugmakers to cut prices on their prescription drugs. Yahoo Finance consumer affairs reporter Jordan Weissmann reviews Trump's latest push to slash drug costs and how the administration may seek to go about it. To watch more expert insights and analysis on the latest market action, check out more Market Domination here.",
    "url": "https://finnhub.io/api/news?id=a52f46ea96cc7f2bee0eca9dc418f58521acc508001fd2d07d07191ce2b8a2f9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747079446,
      "headline": "How Trump could go about executing order to slash drug prices",
      "id": 134408480,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "President Trump signed an executive order on Monday asking drugmakers to cut prices on their prescription drugs. Yahoo Finance consumer affairs reporter Jordan Weissmann reviews Trump's latest push to slash drug costs and how the administration may seek to go about it. To watch more expert insights and analysis on the latest market action, check out more Market Domination here.",
      "url": "https://finnhub.io/api/news?id=a52f46ea96cc7f2bee0eca9dc418f58521acc508001fd2d07d07191ce2b8a2f9"
    }
  },
  {
    "ts": null,
    "headline": "Trump Executive Order Could Reshape How Americans Pay for Drugs. Why It Isn’t Bad for Pharma Stocks.",
    "summary": "The Trump administration’s Monday executive order could restructure how Americans buy prescription drugs, pushing them away from insurers and pharmacy-benefit managers and toward cash-pay options.  A White House official said on a press call early Monday that a new executive order from President Donald Trump will push drugmakers to sell prescription drugs at low prices directly to patients.  President Trump signed the executive order shortly before 11 a.m. after a press conference in which he and top officials railed against the drug industry and painted the order as a blow against drugmakers.",
    "url": "https://finnhub.io/api/news?id=c85eaeebc2895b7b1416d31189f2e5c8040e300bbac9d05b92f5d449c2c98a56",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747076280,
      "headline": "Trump Executive Order Could Reshape How Americans Pay for Drugs. Why It Isn’t Bad for Pharma Stocks.",
      "id": 134408482,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "The Trump administration’s Monday executive order could restructure how Americans buy prescription drugs, pushing them away from insurers and pharmacy-benefit managers and toward cash-pay options.  A White House official said on a press call early Monday that a new executive order from President Donald Trump will push drugmakers to sell prescription drugs at low prices directly to patients.  President Trump signed the executive order shortly before 11 a.m. after a press conference in which he and top officials railed against the drug industry and painted the order as a blow against drugmakers.",
      "url": "https://finnhub.io/api/news?id=c85eaeebc2895b7b1416d31189f2e5c8040e300bbac9d05b92f5d449c2c98a56"
    }
  },
  {
    "ts": null,
    "headline": "50 Fortune World's Most Admired Companies (FWMAC): 24 \"Safer\", 1 Ideal Buy",
    "summary": "These are my top dividend stock picks from Fortune Worldâs Most Admired Companies, May 2025 edition. Read the full report here on Seeking Alpha.",
    "url": "https://finnhub.io/api/news?id=ce6b1e455860c526dd2cb46bd7eb05e757c51e3c22b9d8bfeba114fe20621d90",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747074311,
      "headline": "50 Fortune World's Most Admired Companies (FWMAC): 24 \"Safer\", 1 Ideal Buy",
      "id": 134392206,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/678921557/image_678921557.jpg?io=getty-c-w1536",
      "related": "LLY",
      "source": "SeekingAlpha",
      "summary": "These are my top dividend stock picks from Fortune Worldâs Most Admired Companies, May 2025 edition. Read the full report here on Seeking Alpha.",
      "url": "https://finnhub.io/api/news?id=ce6b1e455860c526dd2cb46bd7eb05e757c51e3c22b9d8bfeba114fe20621d90"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly (NYSE:LLY) Announces Superior Weight Loss Results for Zepbound Over Wegovy",
    "summary": "Eli Lilly (NYSE:LLY) recently announced the impressive results of its SURMOUNT-5 trial, highlighting Zepbound's efficacy over Wegovy in weight management. This promising development was disclosed alongside its participation at the European Congress on Obesity and publication in The New England Journal of Medicine. Despite these headline-grabbing results, Eli Lilly's stock movement remained flat over the last month, aligning with broader market trends, which also showed little change. The...",
    "url": "https://finnhub.io/api/news?id=9909b77ba0b1a08edc0cf736a0d0f78f72529581f547a48ffe8233879c594709",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747070226,
      "headline": "Eli Lilly (NYSE:LLY) Announces Superior Weight Loss Results for Zepbound Over Wegovy",
      "id": 134408484,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Eli Lilly (NYSE:LLY) recently announced the impressive results of its SURMOUNT-5 trial, highlighting Zepbound's efficacy over Wegovy in weight management. This promising development was disclosed alongside its participation at the European Congress on Obesity and publication in The New England Journal of Medicine. Despite these headline-grabbing results, Eli Lilly's stock movement remained flat over the last month, aligning with broader market trends, which also showed little change. The...",
      "url": "https://finnhub.io/api/news?id=9909b77ba0b1a08edc0cf736a0d0f78f72529581f547a48ffe8233879c594709"
    }
  },
  {
    "ts": null,
    "headline": "Fox One, SoftBank delays investment, Zepbound weight loss",
    "summary": "Yahoo Finance host Brad Smith tracks today's top moving stocks and biggest market stories in this Market Minute, including Fox's (FOX, FOXA) new streaming service, Fox One; SoftBank (9434.T) delaying its $100 billion investment into AI infrastructure in the US; and patients using Eli Lilly's (LLY) Zepbound reporting losing more weight than Novo Nordisk's (NVO) Wegovy GLP-1 weight-loss drug. Stay up to date on the latest market action, minute-by-minute, with Yahoo Finance's Market Minute.",
    "url": "https://finnhub.io/api/news?id=6102b687abf20b4ae3fd5ebeeb262a0d8bf69d876572a4c68b236cbf10bb46ba",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747066469,
      "headline": "Fox One, SoftBank delays investment, Zepbound weight loss",
      "id": 134408485,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Yahoo Finance host Brad Smith tracks today's top moving stocks and biggest market stories in this Market Minute, including Fox's (FOX, FOXA) new streaming service, Fox One; SoftBank (9434.T) delaying its $100 billion investment into AI infrastructure in the US; and patients using Eli Lilly's (LLY) Zepbound reporting losing more weight than Novo Nordisk's (NVO) Wegovy GLP-1 weight-loss drug. Stay up to date on the latest market action, minute-by-minute, with Yahoo Finance's Market Minute.",
      "url": "https://finnhub.io/api/news?id=6102b687abf20b4ae3fd5ebeeb262a0d8bf69d876572a4c68b236cbf10bb46ba"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly stock sinks as pharma misses out on the market rally",
    "summary": "Pharma companies were mostly left out of the stock market’s broader rally Monday morning on the news that President Donald Trump would sign an order lowering some drug prices.",
    "url": "https://finnhub.io/api/news?id=7492a417a8b15904037f9d56058365eea072af42500ca61e557c01273557731d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747063500,
      "headline": "Eli Lilly stock sinks as pharma misses out on the market rally",
      "id": 134408487,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Pharma companies were mostly left out of the stock market’s broader rally Monday morning on the news that President Donald Trump would sign an order lowering some drug prices.",
      "url": "https://finnhub.io/api/news?id=7492a417a8b15904037f9d56058365eea072af42500ca61e557c01273557731d"
    }
  },
  {
    "ts": null,
    "headline": "Trump expected to sign order to slash US drug prices",
    "summary": "President Trump is expected to sign an executive order intended to cut US prescription drug prices in order to match drug prices overseas. Yahoo Finance senior health reporter Anjalee Khemlani outlines the many steps and government agencies involved in investigating and carrying out this act. To watch more expert insights and analysis on the latest market action, check out more Morning Brief here.",
    "url": "https://finnhub.io/api/news?id=2fac8407bab8089ee6638e31408578326a93679e005cdef8d76c714e3eae16d7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747061072,
      "headline": "Trump expected to sign order to slash US drug prices",
      "id": 134381623,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "President Trump is expected to sign an executive order intended to cut US prescription drug prices in order to match drug prices overseas. Yahoo Finance senior health reporter Anjalee Khemlani outlines the many steps and government agencies involved in investigating and carrying out this act. To watch more expert insights and analysis on the latest market action, check out more Morning Brief here.",
      "url": "https://finnhub.io/api/news?id=2fac8407bab8089ee6638e31408578326a93679e005cdef8d76c714e3eae16d7"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly Says Trial Patients Lost More Weight on Zepbound Than Rival’s Wegovy",
    "summary": "The obesity drug helped patients reduce their waist size by an extra two inches compared to those on Novo Nordisk’s Wegovy in a head-to-head study of the two drugs.",
    "url": "https://finnhub.io/api/news?id=d55a04f665060ce1c0323a476f39873a01e6620883f7a37ac897528666212d2c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747055520,
      "headline": "Eli Lilly Says Trial Patients Lost More Weight on Zepbound Than Rival’s Wegovy",
      "id": 134379226,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "The obesity drug helped patients reduce their waist size by an extra two inches compared to those on Novo Nordisk’s Wegovy in a head-to-head study of the two drugs.",
      "url": "https://finnhub.io/api/news?id=d55a04f665060ce1c0323a476f39873a01e6620883f7a37ac897528666212d2c"
    }
  },
  {
    "ts": null,
    "headline": "US-China trade truce, April CPI, drug prices: 3 Things",
    "summary": "US stock futures (ES=F, NQ=F, YM=F) are surging Monday morning after US and China officials agreed to significant cuts to each country's respective tariff rates in a 90-day cool-off period. April's Consumer Price Index (CPI) is due out tomorrow, reporting month-over-month trends in US inflation rates. President Trump vows to cut prescription drug prices by as much as 80%. In turn, pharmaceutical stocks are seeing across the board pullbacks in pre-market trading. To watch more expert insights and analysis on the latest market action, check out more Morning Brief here.",
    "url": "https://finnhub.io/api/news?id=a938c055665a43b53f0a2cfa14795093ec3154f152ae163fa36fccfba6e48a3b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747055379,
      "headline": "US-China trade truce, April CPI, drug prices: 3 Things",
      "id": 134379227,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "US stock futures (ES=F, NQ=F, YM=F) are surging Monday morning after US and China officials agreed to significant cuts to each country's respective tariff rates in a 90-day cool-off period. April's Consumer Price Index (CPI) is due out tomorrow, reporting month-over-month trends in US inflation rates. President Trump vows to cut prescription drug prices by as much as 80%. In turn, pharmaceutical stocks are seeing across the board pullbacks in pre-market trading. To watch more expert insights and analysis on the latest market action, check out more Morning Brief here.",
      "url": "https://finnhub.io/api/news?id=a938c055665a43b53f0a2cfa14795093ec3154f152ae163fa36fccfba6e48a3b"
    }
  },
  {
    "ts": null,
    "headline": "These Stocks Are Moving the Most Today: Amazon, Nvidia, Tesla, Alibaba, Eli Lilly, Pfizer, RH, Newmont, and More",
    "summary": "Amazon.com, Nvidia, Tesla, and the rest of the Magnificent Seven stocks jump as the U.S. and China reach an agreement to temporarily slash most tariffs on each other’s goods, while Eli Lilly and Pfizer fall after President Donald Trump plans to sign an executive order that would reduce the cost of drugs in the U.S.",
    "url": "https://finnhub.io/api/news?id=66342666979fcde83bc5dd4acbe8c772e03dd3f8e71e70d5edb4be570b421ba7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747055040,
      "headline": "These Stocks Are Moving the Most Today: Amazon, Nvidia, Tesla, Alibaba, Eli Lilly, Pfizer, RH, Newmont, and More",
      "id": 134379091,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Amazon.com, Nvidia, Tesla, and the rest of the Magnificent Seven stocks jump as the U.S. and China reach an agreement to temporarily slash most tariffs on each other’s goods, while Eli Lilly and Pfizer fall after President Donald Trump plans to sign an executive order that would reduce the cost of drugs in the U.S.",
      "url": "https://finnhub.io/api/news?id=66342666979fcde83bc5dd4acbe8c772e03dd3f8e71e70d5edb4be570b421ba7"
    }
  },
  {
    "ts": null,
    "headline": "Trump Declares War On Pharma Drug Pricing, But The Stocks Aren't Tanking - Yet",
    "summary": "Trump aims to cut US drug prices by 30-80% via Executive Order. Check out how pharma companies could be affected and how this may play out in the future.",
    "url": "https://finnhub.io/api/news?id=f3bdfb278b3d923fb7ecd9a0eb0a6ca51ad748153503c12329641a35d2d60c57",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747053003,
      "headline": "Trump Declares War On Pharma Drug Pricing, But The Stocks Aren't Tanking - Yet",
      "id": 134386076,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1756275584/image_1756275584.jpg?io=getty-c-w1536",
      "related": "LLY",
      "source": "SeekingAlpha",
      "summary": "Trump aims to cut US drug prices by 30-80% via Executive Order. Check out how pharma companies could be affected and how this may play out in the future.",
      "url": "https://finnhub.io/api/news?id=f3bdfb278b3d923fb7ecd9a0eb0a6ca51ad748153503c12329641a35d2d60c57"
    }
  },
  {
    "ts": null,
    "headline": "Novo Nordisk Stock Is Slumping Today. Here’s Why.",
    "summary": "Shares of the Ozempic-maker fell while the rest of the market rose,as it's facing a hit to revenue from different directions.",
    "url": "https://finnhub.io/api/news?id=b1b453060d392d6b4c1c4dcf0272cf295e86d46171b379a5872ec04b1f492cbc",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747052580,
      "headline": "Novo Nordisk Stock Is Slumping Today. Here’s Why.",
      "id": 134379229,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Shares of the Ozempic-maker fell while the rest of the market rose,as it's facing a hit to revenue from different directions.",
      "url": "https://finnhub.io/api/news?id=b1b453060d392d6b4c1c4dcf0272cf295e86d46171b379a5872ec04b1f492cbc"
    }
  },
  {
    "ts": null,
    "headline": "Novo Nordisk Tumbles as Lilly's  Zepbound Shows Greater Weight Loss in Trial",
    "summary": "Eli Lilly's Zepbound Beats Wegovy, Sends Novo Nordisk Stock Lower",
    "url": "https://finnhub.io/api/news?id=a2ab1da076cc151cc1048987c9d40c2c0596621521c5f7f0824a3ef97c170c0c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747052214,
      "headline": "Novo Nordisk Tumbles as Lilly's  Zepbound Shows Greater Weight Loss in Trial",
      "id": 134379230,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Eli Lilly's Zepbound Beats Wegovy, Sends Novo Nordisk Stock Lower",
      "url": "https://finnhub.io/api/news?id=a2ab1da076cc151cc1048987c9d40c2c0596621521c5f7f0824a3ef97c170c0c"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer, Eli Lilly, Merck and Other Pharma Stocks Fall as Trump Targets Lower Drug Prices",
    "summary": "Shares of pharmaceutical companies dropped early Monday after President Donald Trump said he would lower the cost of medicines for Americans by 59%.  Shares of major U.S. drugmakers  Eli Lilly Pfizer Merck AbbVie  and  Amgen  fell between 2.4% and 4.3% in premarket trading Monday.  The U.S. is the largest market for many global pharmaceutical companies, partly because of higher prices.",
    "url": "https://finnhub.io/api/news?id=47a39c86dd44bb5d036c37fde583aa7df5427ad596f3a9fdfb9d2166d7ec8dbf",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747050540,
      "headline": "Pfizer, Eli Lilly, Merck and Other Pharma Stocks Fall as Trump Targets Lower Drug Prices",
      "id": 134379231,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Shares of pharmaceutical companies dropped early Monday after President Donald Trump said he would lower the cost of medicines for Americans by 59%.  Shares of major U.S. drugmakers  Eli Lilly Pfizer Merck AbbVie  and  Amgen  fell between 2.4% and 4.3% in premarket trading Monday.  The U.S. is the largest market for many global pharmaceutical companies, partly because of higher prices.",
      "url": "https://finnhub.io/api/news?id=47a39c86dd44bb5d036c37fde583aa7df5427ad596f3a9fdfb9d2166d7ec8dbf"
    }
  },
  {
    "ts": null,
    "headline": "Trump’s Vow to Cut US Drug Prices Drags Pharma Stocks Lower",
    "summary": "(Bloomberg) -- President Donald Trump said he plans to order a cut in US prescription drug costs to bring them in line with other countries, spurring a drop in pharmaceutical shares worldwide.Most Read from BloombergA New Central Park Amenity, Tailored to Its East Harlem NeighborsAs Trump Reshapes Housing Policy, Renters Face Rollback of RightsWhat’s Behind the Rise in Serious Injuries on New York City’s Streets?Is Trump’s Plan to Reopen the Notorious Alcatraz Prison Realistic?NYC Warns of 17% D",
    "url": "https://finnhub.io/api/news?id=0ed68ac2f804ddcc0a1868fcbb1408e4d02677fcb05f84f561f6989bfb263898",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747049896,
      "headline": "Trump’s Vow to Cut US Drug Prices Drags Pharma Stocks Lower",
      "id": 134379232,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "(Bloomberg) -- President Donald Trump said he plans to order a cut in US prescription drug costs to bring them in line with other countries, spurring a drop in pharmaceutical shares worldwide.Most Read from BloombergA New Central Park Amenity, Tailored to Its East Harlem NeighborsAs Trump Reshapes Housing Policy, Renters Face Rollback of RightsWhat’s Behind the Rise in Serious Injuries on New York City’s Streets?Is Trump’s Plan to Reopen the Notorious Alcatraz Prison Realistic?NYC Warns of 17% D",
      "url": "https://finnhub.io/api/news?id=0ed68ac2f804ddcc0a1868fcbb1408e4d02677fcb05f84f561f6989bfb263898"
    }
  },
  {
    "ts": null,
    "headline": "These Stocks Are Moving the Most Today: Amazon, Nvidia, Tesla, Alibaba, Eli Lilly, Pfizer, NRG Energy, Newmont, and More",
    "summary": "These Stocks Are Moving the Most Today: Amazon, Nvidia, Tesla, Alibaba, Eli Lilly, Pfizer, NRG Energy, Newmont, and More",
    "url": "https://finnhub.io/api/news?id=87d0575998f551ca18e458ff9de4f28fd25a567b3beef1aeada1239f92bcb089",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747049280,
      "headline": "These Stocks Are Moving the Most Today: Amazon, Nvidia, Tesla, Alibaba, Eli Lilly, Pfizer, NRG Energy, Newmont, and More",
      "id": 134382364,
      "image": "",
      "related": "LLY",
      "source": "MarketWatch",
      "summary": "These Stocks Are Moving the Most Today: Amazon, Nvidia, Tesla, Alibaba, Eli Lilly, Pfizer, NRG Energy, Newmont, and More",
      "url": "https://finnhub.io/api/news?id=87d0575998f551ca18e458ff9de4f28fd25a567b3beef1aeada1239f92bcb089"
    }
  },
  {
    "ts": null,
    "headline": "20 stocks of companies showing excellent earnings-season trends even as the economy cools",
    "summary": "20 stocks of companies showing excellent earnings-season trends even as the economy cools",
    "url": "https://finnhub.io/api/news?id=2b9b748253f3fa06d5c9d5489e045eec892750ef2b43160eec9dc5c9f7e8d794",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747048680,
      "headline": "20 stocks of companies showing excellent earnings-season trends even as the economy cools",
      "id": 134382833,
      "image": "",
      "related": "LLY",
      "source": "MarketWatch",
      "summary": "20 stocks of companies showing excellent earnings-season trends even as the economy cools",
      "url": "https://finnhub.io/api/news?id=2b9b748253f3fa06d5c9d5489e045eec892750ef2b43160eec9dc5c9f7e8d794"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly and Company - Zepbound showed superior weight loss over Wegovy in complete SURMOUNT-5 results published in The New England Journal of Medicine",
    "summary": "INDIANAPOLIS - Eli Lilly and Company announced detailed results from SURMOUNT-5, a Phase 3b open-label clinical trial, evaluating the safety and efficacy of Zepbound , a dual GIP and GLP-1 receptor...",
    "url": "https://finnhub.io/api/news?id=cc7bdbe7b4c6161501daf86d8f1920b4d21d293c17979919352e83e48b700a96",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747048455,
      "headline": "Eli Lilly and Company - Zepbound showed superior weight loss over Wegovy in complete SURMOUNT-5 results published in The New England Journal of Medicine",
      "id": 134381911,
      "image": "",
      "related": "LLY",
      "source": "Finnhub",
      "summary": "INDIANAPOLIS - Eli Lilly and Company announced detailed results from SURMOUNT-5, a Phase 3b open-label clinical trial, evaluating the safety and efficacy of Zepbound , a dual GIP and GLP-1 receptor...",
      "url": "https://finnhub.io/api/news?id=cc7bdbe7b4c6161501daf86d8f1920b4d21d293c17979919352e83e48b700a96"
    }
  },
  {
    "ts": null,
    "headline": "Trump Executive Order Reshapes How Americans Pay for Drugs. Why It Isn’t Bad for Pharma Stocks.",
    "summary": "Trump Executive Order Reshapes How Americans Pay for Drugs. Why It Isn’t Bad for Pharma Stocks.",
    "url": "https://finnhub.io/api/news?id=af5b4ecb8b18eb30bc64e99d843a62e1036afca940ad279f70fdb98e2995aa97",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747048140,
      "headline": "Trump Executive Order Reshapes How Americans Pay for Drugs. Why It Isn’t Bad for Pharma Stocks.",
      "id": 134382834,
      "image": "",
      "related": "LLY",
      "source": "MarketWatch",
      "summary": "Trump Executive Order Reshapes How Americans Pay for Drugs. Why It Isn’t Bad for Pharma Stocks.",
      "url": "https://finnhub.io/api/news?id=af5b4ecb8b18eb30bc64e99d843a62e1036afca940ad279f70fdb98e2995aa97"
    }
  },
  {
    "ts": null,
    "headline": "S&P 500, Dow Jones Pharma Stocks Boomerang As Trump Threatens Drug-Price Reform",
    "summary": "S&P 500, Dow Jones Pharma Stocks Boomerang As Trump Threatens Drug-Price Reform",
    "url": "https://finnhub.io/api/news?id=fbd600c371c29b6507227d096a81cc6d336a75dab9a96dd728fa103a5c6c45ae",
    "source": "DowJones",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747044043,
      "headline": "S&P 500, Dow Jones Pharma Stocks Boomerang As Trump Threatens Drug-Price Reform",
      "id": 134382803,
      "image": "",
      "related": "LLY",
      "source": "DowJones",
      "summary": "S&P 500, Dow Jones Pharma Stocks Boomerang As Trump Threatens Drug-Price Reform",
      "url": "https://finnhub.io/api/news?id=fbd600c371c29b6507227d096a81cc6d336a75dab9a96dd728fa103a5c6c45ae"
    }
  },
  {
    "ts": null,
    "headline": "Here’s how much extra weight is lost with Zepbound over Wegovy",
    "summary": "Here’s how much extra weight is lost with Zepbound over Wegovy",
    "url": "https://finnhub.io/api/news?id=36ffde78cbc02da9ddb46214d4a838fc7b6e72bac8fcd907f1b52ffef456722f",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747042980,
      "headline": "Here’s how much extra weight is lost with Zepbound over Wegovy",
      "id": 134382837,
      "image": "",
      "related": "LLY",
      "source": "MarketWatch",
      "summary": "Here’s how much extra weight is lost with Zepbound over Wegovy",
      "url": "https://finnhub.io/api/news?id=36ffde78cbc02da9ddb46214d4a838fc7b6e72bac8fcd907f1b52ffef456722f"
    }
  },
  {
    "ts": null,
    "headline": "Trending tickers: Tesla, Alibaba, Eli Lilly, Novo Nordisk and Glencore",
    "summary": "The latest investor updates on stocks that are trending on Monday.",
    "url": "https://finnhub.io/api/news?id=ad0aa0c1021271d6687a3b0c5e49fc7d00b088a6d5647963ce6399135255b0cd",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747042404,
      "headline": "Trending tickers: Tesla, Alibaba, Eli Lilly, Novo Nordisk and Glencore",
      "id": 134379189,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "The latest investor updates on stocks that are trending on Monday.",
      "url": "https://finnhub.io/api/news?id=ad0aa0c1021271d6687a3b0c5e49fc7d00b088a6d5647963ce6399135255b0cd"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly Says Trial Patients Lost More Weight on Zepbound Than Rival's Wegovy",
    "summary": "By Dominic Chopping Eli Lilly said its Zepbound obesity drug helped patients reduce their waist size by an extra two inches compared to those on Novo Nordisk's Wegovy in a head-to-head study of...",
    "url": "https://finnhub.io/api/news?id=008a1db8158099840001b94da74dec07f6a099fdda90832bcdd6871e60332039",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747041488,
      "headline": "Eli Lilly Says Trial Patients Lost More Weight on Zepbound Than Rival's Wegovy",
      "id": 134378758,
      "image": "",
      "related": "LLY",
      "source": "Finnhub",
      "summary": "By Dominic Chopping Eli Lilly said its Zepbound obesity drug helped patients reduce their waist size by an extra two inches compared to those on Novo Nordisk's Wegovy in a head-to-head study of...",
      "url": "https://finnhub.io/api/news?id=008a1db8158099840001b94da74dec07f6a099fdda90832bcdd6871e60332039"
    }
  },
  {
    "ts": null,
    "headline": "Lilly-Purdue partnership to invest $250m in pharma innovation",
    "summary": "The partnership is anticipated to yield economic benefits for Indiana, enhancing innovation locally.",
    "url": "https://finnhub.io/api/news?id=6ac627952e6191a0f56b53e407ad99ca214135691115e53b91d878754ad7c565",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747040765,
      "headline": "Lilly-Purdue partnership to invest $250m in pharma innovation",
      "id": 134379234,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "The partnership is anticipated to yield economic benefits for Indiana, enhancing innovation locally.",
      "url": "https://finnhub.io/api/news?id=6ac627952e6191a0f56b53e407ad99ca214135691115e53b91d878754ad7c565"
    }
  },
  {
    "ts": null,
    "headline": "Pharmaceutical Stocks Tumble on Trump Plan to Cut US Drug Prices",
    "summary": "(Bloomberg) -- Shares of pharmaceutical companies fell across the world after US President Donald Trump said he planned to order a cut in US prescription drug costs to bring them in line with other countries, prompting concern that profits will take a hit.Most Read from BloombergA New Central Park Amenity, Tailored to Its East Harlem NeighborsAs Trump Reshapes Housing Policy, Renters Face Rollback of RightsWhat’s Behind the Rise in Serious Injuries on New York City’s Streets?Is Trump’s Plan to R",
    "url": "https://finnhub.io/api/news?id=803a34c4b75b272c31602fdb892079821fd3c2013e3b55a564d6bf5776762dd1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747038493,
      "headline": "Pharmaceutical Stocks Tumble on Trump Plan to Cut US Drug Prices",
      "id": 134379236,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "(Bloomberg) -- Shares of pharmaceutical companies fell across the world after US President Donald Trump said he planned to order a cut in US prescription drug costs to bring them in line with other countries, prompting concern that profits will take a hit.Most Read from BloombergA New Central Park Amenity, Tailored to Its East Harlem NeighborsAs Trump Reshapes Housing Policy, Renters Face Rollback of RightsWhat’s Behind the Rise in Serious Injuries on New York City’s Streets?Is Trump’s Plan to R",
      "url": "https://finnhub.io/api/news?id=803a34c4b75b272c31602fdb892079821fd3c2013e3b55a564d6bf5776762dd1"
    }
  },
  {
    "ts": null,
    "headline": "Novo Nordisk: Nothing Has Changed, Except That It's Cheaper Now",
    "summary": "Novo Nordisk's competitive position is strengthening, driven by strong sales growth in Wegovy, Ozempic, and rare diseases. See why NVO stock is a Buy.",
    "url": "https://finnhub.io/api/news?id=956fcb34329dc33b773d0666b05cd80b960d66804bb968ad1c4057e2179498a5",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747030935,
      "headline": "Novo Nordisk: Nothing Has Changed, Except That It's Cheaper Now",
      "id": 134377046,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1455239157/image_1455239157.jpg?io=getty-c-w1536",
      "related": "LLY",
      "source": "SeekingAlpha",
      "summary": "Novo Nordisk's competitive position is strengthening, driven by strong sales growth in Wegovy, Ozempic, and rare diseases. See why NVO stock is a Buy.",
      "url": "https://finnhub.io/api/news?id=956fcb34329dc33b773d0666b05cd80b960d66804bb968ad1c4057e2179498a5"
    }
  },
  {
    "ts": null,
    "headline": "3 Healthcare Stocks to Keep an Eye On",
    "summary": "Personal health and wellness is one of the many secular tailwinds for healthcare companies. But financial performance has lagged recently as players offloaded surplus COVID inventories in 2023 and 2024, a headwind for overall demand. The result? Over the past six months, the industry has tumbled by 13%. This drop was worse than the S&P 500’s 5.5% loss.",
    "url": "https://finnhub.io/api/news?id=e1dac777df2a872959d8835ca403acadd2a82fc9410b2f791a4900dc16745a5e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747024811,
      "headline": "3 Healthcare Stocks to Keep an Eye On",
      "id": 134379238,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Personal health and wellness is one of the many secular tailwinds for healthcare companies. But financial performance has lagged recently as players offloaded surplus COVID inventories in 2023 and 2024, a headwind for overall demand. The result? Over the past six months, the industry has tumbled by 13%. This drop was worse than the S&P 500’s 5.5% loss.",
      "url": "https://finnhub.io/api/news?id=e1dac777df2a872959d8835ca403acadd2a82fc9410b2f791a4900dc16745a5e"
    }
  },
  {
    "ts": null,
    "headline": "Trump Renews Push for Most-Favored-Nation Drug Pricing. What It All Means.",
    "summary": "Trump Renews Push for Most-Favored-Nation Drug Pricing. What It All Means.",
    "url": "https://finnhub.io/api/news?id=2f17615fa3dc3229d7cead908effa15fa28091274631f5b10eb144d739354714",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747013400,
      "headline": "Trump Renews Push for Most-Favored-Nation Drug Pricing. What It All Means.",
      "id": 134382838,
      "image": "",
      "related": "LLY",
      "source": "MarketWatch",
      "summary": "Trump Renews Push for Most-Favored-Nation Drug Pricing. What It All Means.",
      "url": "https://finnhub.io/api/news?id=2f17615fa3dc3229d7cead908effa15fa28091274631f5b10eb144d739354714"
    }
  },
  {
    "ts": null,
    "headline": "Meta, Walmart, and Other Stocks This AI Trader Is Selling Amid the Market Uncertainty",
    "summary": "Meta, Walmart, and Other Stocks This AI Trader Is Selling Amid the Market Uncertainty",
    "url": "https://finnhub.io/api/news?id=6419412bccdb7ea33bbc6319fc485331c2130fa7eb88f71a67c3f51de0522b9f",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747011600,
      "headline": "Meta, Walmart, and Other Stocks This AI Trader Is Selling Amid the Market Uncertainty",
      "id": 134382455,
      "image": "",
      "related": "LLY",
      "source": "MarketWatch",
      "summary": "Meta, Walmart, and Other Stocks This AI Trader Is Selling Amid the Market Uncertainty",
      "url": "https://finnhub.io/api/news?id=6419412bccdb7ea33bbc6319fc485331c2130fa7eb88f71a67c3f51de0522b9f"
    }
  }
]